首页> 外文OA文献 >Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.
【2h】

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.

机译:磷脂酶D3基因中罕见的编码变异会增加患阿尔茨海默氏病的风险。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genome-wide association studies (GWAS) have identified several risk variants for late-onset Alzheimer's disease (LOAD). These common variants have replicable but small effects on LOAD risk and generally do not have obvious functional effects. Low-frequency coding variants, not detected by GWAS, are predicted to include functional variants with larger effects on risk. To identify low-frequency coding variants with large effects on LOAD risk, we carried out whole-exome sequencing (WES) in 14 large LOAD families and follow-up analyses of the candidate variants in several large LOAD case-control data sets. A rare variant in PLD3 (phospholipase D3; Val232Met) segregated with disease status in two independent families and doubled risk for Alzheimer's disease in seven independent case-control series with a total of more than 11,000 cases and controls of European descent. Gene-based burden analyses in 4,387 cases and controls of European descent and 302 African American cases and controls, with complete sequence data for PLD3, reveal that several variants in this gene increase risk for Alzheimer's disease in both populations. PLD3 is highly expressed in brain regions that are vulnerable to Alzheimer's disease pathology, including hippocampus and cortex, and is expressed at significantly lower levels in neurons from Alzheimer's disease brains compared to control brains. Overexpression of PLD3 leads to a significant decrease in intracellular amyloid-β precursor protein (APP) and extracellular Aβ42 and Aβ40 (the 42- and 40-residue isoforms of the amyloid-β peptide), and knockdown of PLD3 leads to a significant increase in extracellular Aβ42 and Aβ40. Together, our genetic and functional data indicate that carriers of PLD3 coding variants have a twofold increased risk for LOAD and that PLD3 influences APP processing. This study provides an example of how densely affected families may help to identify rare variants with large effects on risk for disease or other complex traits.
机译:全基因组关联研究(GWAS)已经确定了晚期阿尔茨海默氏病(LOAD)的几种风险变异。这些常见变体对LOAD风险具有可复制性但影响很小,并且通常没有明显的功能影响。 GWAS未检测到的低频编码变体预计将包含对风险有较大影响的功能变体。为了确定对LOAD风险有较大影响的低频编码变体,我们在14个大LOAD家族中进行了全外显子测序(WES),并对多个大型LOAD病例对照数据集中的候选变体进行了后续分析。 PLD3中的一种罕见变体(磷脂酶D3; Val232Met)在两个独立的家族中与疾病状况隔离开来,在七个独立的病例对照系列中,阿尔茨海默氏病的风险增加了一倍,总共有超过11,000例欧洲血统的病例和对照。对欧洲人后裔的4,387例病例和对照以及302名非裔美国人的病例和对照进行基于基因的负担分析,加上PLD3的完整序列数据,揭示了该基因的多个变异体在两个人群中均增加了患阿尔茨海默氏病的风险。 PLD3在容易患阿尔茨海默氏病病理的大脑区域(包括海马和皮层)中高表达,并且与对照组相比,在阿尔茨海默氏病脑中的神经元中表达水平低得多。 PLD3的过表达导致细胞内淀粉样β-前体蛋白(APP)以及细胞外Aβ42和Aβ40(淀粉样β-肽的42和40个残基亚型)显着降低,而敲低PLD3则导致PLD3的显着增加。细胞外Aβ42和Aβ40。总之,我们的遗传和功能数据表明,PLD3编码变体的携带者对LOAD的风险增加了两倍,并且PLD3影响APP的加工。这项研究提供了一个例子,说明受灾较重的家庭如何帮助确定对疾病或其他复杂性状的风险有重大影响的稀有变异。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号